Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-16-007292
Filing Date
2016-05-10
Accepted
2016-05-10 16:06:47
Documents
41
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT crmd_10q.htm 10-Q 695687
2 BYLAWS, AMENDED AS OF APRIL 19, 2016 crmd_ex31.htm EX-3.1 90359
3 SECOND EXTENSION OF EXECUTIVE EMPLOYMENT AGREEMENT crmd_ex101.htm EX-10.1 23794
4 CERTIFICATION crmd_ex311.htm EX-31.1 14137
5 CERTIFICATION crmd_ex321.htm EX-32.1 6401
  Complete submission text file 0001354488-16-007292.txt   3134464

Data Files

Seq Description Document Type Size
6 crmd-20160331.xml EX-101.INS 604536
7 crmd-20160331.xsd EX-101.SCH 22701
8 crmd-20160331_cal.xml EX-101.CAL 39647
9 crmd-20160331_def.xml EX-101.DEF 76893
10 crmd-20160331_lab.xml EX-101.LAB 220765
11 crmd-20160331_pre.xml EX-101.PRE 161490
Mailing Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921
Business Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 161635790
SIC: 2834 Pharmaceutical Preparations